Stock Updates

GlaxoSmithKline plc (NYSE: GSK) – Is this large market cap stock undervalued?

GlaxoSmithKline plc (NYSE: GSK), is firmly in the large market cap category with market cap of 105964.81. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for GlaxoSmithKline plc is 43.67 (with a change from open of -0.11%), this in conjunction with a target price of 48.67. Volume today has so far reached 1957500, with an average volume of about 2859.72. The GAP for this stock, is 0.92%.

The P/E ratio is 3119.29, bringing the forward P/E to a value of 15.79. The current EPS for GlaxoSmithKline plc, is 0.01, with a EPS growth for this year coming to a value of 204.10%. Performance has been interesting with performance year to date coming to 14.43%.

Looking further into the growth statistics for GlaxoSmithKline plc, EPS is looking like it will grow 6.47% in the next year. Looking even further it is projected to be 10.00%. Quarter over quarter is -392.80% for EPS growth and for sales growth quarter over quarter it is 10.90%. Looking at past EPS growth statistics we see that for the past five years it has been 40.20%. Sales growth for the past five years has in fact been -3.40%.

Looking at the ownership, we see that the insider ownership is at 0.20% and institutional ownership is 9.10%. Shares outstanding is 2426.49, while shares float is at a value of 2416.83. Float short for GlaxoSmithKline plc is 0.29% and the short ratio is 2.47.

In terms of debt, long term debt/equity is 26.3, while the total debt/equity comes to 34.12. The ability to meet these debts, means that the current ratio is 0.9, and the quick ratio is 0.6. The most recent gross margin is 66.60% and their operating margin is 5.30%. The profit margin is 0.10%.

GlaxoSmithKline plc has seen returns on assets of 0.10%, and on investment, 41.40%. Return on equity is 0.90%. Price/Earnings to growth ratio is 311.93. Price/Sales ratio is at a value of 3.24, with Price/book ratio coming to 140.87 and Price/cash is 17.48, and finally Price/Free cash Flow is *TBA.

The simple moving averages are -0.27% and 6.72% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -3.10% and the 52 week low is 25.74%.

GlaxoSmithKline plc has a dividend yield of 5.04%, with a current price of 43.67. The ability to pay this means the payout ratio is *TBA. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. GlaxoSmithKline plc is based in United Kingdom.

Performance in the Drug Manufacturers – Major industry means that GlaxoSmithKline plc has seen performance for the past week of 1.06%, with performance for the month coming to 0.14%. Looking at the data for the quarter it is at a value of 4.02%, and for the half year the performance is 24.67%. Volatility for this week is 0.94% and for the month this is 1.03%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment